Pyrosequencing technology and the need for versatile solutions in molecular clinical research.
An increasing amount of genetic information is rapidly becoming available to the practitioners of medicine and pharmacology. This knowledge promises to revolutionize the determination of diagnoses and prognoses for genetically-based disorders as well as infectious diseases and to enable tailoring of treatment to suit the individual patient. As genomics becomes ripe for clinical implementation, versatile technologies that can handle all the relevant types of analyses will be requested by many clinicians. The recently established Pyrosequencing technology for rapid determination of short DNA sequences has gained widespread acceptance and is being used in a broad range of applications. It can provide a solution for many emerging issues in molecular clinical research and applications, owing to its reliability and high flexibility together with its user-friendly attributes.
Department of Research and Development, Pyrosequencing AB, Vallongatan 1, SE-752 28 Uppsala, Sweden. Lars.Berg@pyrosequencing.com
Lars M
LM
Berg
Rhiannon
R
Sanders
Anders
A
Alderborn
D035843:Biomedical Research; D004247:DNA / Q000032:analysis; D011756:Diphosphates / Q000378:metabolism*; D005544:Forecasting; D009154:Mutation; D020641:Polymorphism, Single Nucleotide; D017422:Sequence Analysis, DNA / Q000295:instrumentation / Q000379:methods* / Q000639:trends
D011756:Diphosphates; D004247:DNA